BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

604 related articles for article (PubMed ID: 11654756)

  • 1. Ethical considerations in informed consent for potential future use of human tissue samples.
    Adams M; Prentice ED; Oki GS
    IRB; 1996; 18(2):6-7. PubMed ID: 11654756
    [No Abstract]   [Full Text] [Related]  

  • 2. Moore v. Regents of the University of California: expanded disclosure, limited property rights.
    Potts J
    Northwest Univ Law Rev; 1992; 86(2):453-96. PubMed ID: 11659500
    [No Abstract]   [Full Text] [Related]  

  • 3. Research that could yield marketable products from human materials: the problem of informed consent.
    Levine RJ
    IRB; 1986; 8(1):6-7. PubMed ID: 11649703
    [No Abstract]   [Full Text] [Related]  

  • 4. The case for per patient payments.
    Lewis JP
    IRB; 1988; 10(5):9. PubMed ID: 11650075
    [No Abstract]   [Full Text] [Related]  

  • 5. Power, advocacy, and informed consent forms.
    Smith ML
    J Calif Alliance Ment Ill; 1994; 5(1):25-7. PubMed ID: 11653311
    [No Abstract]   [Full Text] [Related]  

  • 6. Why I oppose drug company payment of physician/investigators on a per patient/subject basis.
    Roizen R
    IRB; 1988; 10(1):9-10. PubMed ID: 11658990
    [No Abstract]   [Full Text] [Related]  

  • 7. Who owns the body? On the ethics of using human tissues for commercial purposes.
    Murray TH
    IRB; 1986; 8(1):1-5. PubMed ID: 11649702
    [No Abstract]   [Full Text] [Related]  

  • 8. Homo economicus: commercialization of body tissue in the age of biotechnology.
    Nelkin D; Andrews L
    Hastings Cent Rep; 1998; 28(5):30-9. PubMed ID: 11656768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human tissue research: who owns the results?
    Wagner AB
    J Pat Trademark Off Soc; 1987 Jun; 69(6):329-52. PubMed ID: 11649984
    [No Abstract]   [Full Text] [Related]  

  • 10. Consent to use of discarded tissues: another impact of AIDS.
    Holder AR
    IRB; 1987; 9(5):10-1. PubMed ID: 11649897
    [No Abstract]   [Full Text] [Related]  

  • 11. DNA banking and informed consent -- part 1.
    Weir RF; Horton JR
    IRB; 1995; 17(4):1-4. PubMed ID: 11654216
    [No Abstract]   [Full Text] [Related]  

  • 12. Protocol review within the context of a research program.
    Miller FG; Rosenstein DL
    IRB; 1998; 20(4):7-10. PubMed ID: 11657088
    [No Abstract]   [Full Text] [Related]  

  • 13. Patient autonomy and biomedical research: judicial compromise in Moore v. Regents of the University of California.
    LoBiondo AR
    Albany Law J Sci Technol; 1991; 1():277-305. PubMed ID: 16281328
    [No Abstract]   [Full Text] [Related]  

  • 14. Toward the right of commerciality: recognizing property rights in the commercial value of human tissue.
    Hardiman R
    UCLA Law Rev; 1986 Oct; 34(1):207-64. PubMed ID: 11659048
    [No Abstract]   [Full Text] [Related]  

  • 15. Research fraud, misconduct, and the IRB.
    Hilgartner S
    IRB; 1990; 12(1):1-4. PubMed ID: 11651971
    [No Abstract]   [Full Text] [Related]  

  • 16. Perspectives of protocol reviewers.
    Moline ML; Aisen MW
    J Calif Alliance Ment Ill; 1994; 5(1):59-60. PubMed ID: 11653327
    [No Abstract]   [Full Text] [Related]  

  • 17. Conflict + interest: financial incentives and informed consent in human subject research.
    Benbow S
    Notre Dame J Law Ethics Public Policy; 2003; 17(1):181-215. PubMed ID: 14986653
    [No Abstract]   [Full Text] [Related]  

  • 18. The control of living body materials.
    Dickens BM
    Univ Tor Law J; 1977; 27(2):142-98. PubMed ID: 11660914
    [No Abstract]   [Full Text] [Related]  

  • 19. Conflict of interest in human research ethics.
    Jones DJ
    NCBHR Commun; 1995; 6(2):5-10. PubMed ID: 11654611
    [No Abstract]   [Full Text] [Related]  

  • 20. Informed consent: defining limits through therapeutic parameters.
    Daar JF
    Whittier Law Rev; 1995; 16(1):187-209. PubMed ID: 11660487
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 31.